Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy

scientific article published on July 1988

Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1200/JCO.1988.6.7.1107
P698PubMed publication ID3292711

P2093author name stringS Taylor
R Gray
R L Goodman
D C Tormey
B Fowble
K Gilchrist
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectbreast cancerQ128581
adaptive radiation therapyQ180507
chemotherapyQ974135
P304page(s)1107-1117
P577publication date1988-07-01
P1433published inJournal of Clinical OncologyQ400292
P1476titleIdentification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy
P478volume6

Reverse relations

cites work (P2860)
Q41345528"One to three" or "four or more"?: selecting patients for postmastectomy radiation therapy
Q74682555A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger
Q67789583A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer. Eleven year follow-up of a Piedmont Oncology Association trial
Q34033287Adjuvant radiotherapy in breast cancer--the treatment of lymph node areas.
Q71116491Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients
Q40704208Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends
Q40815799Assessing the cost-effectiveness of postmastectomy radiation therapy
Q74610173Biased methods for estimating local and distant failure rates in breast carcinoma and a "commonsense" approach
Q42316284Breast Carcinosarcomas
Q33446778Breast cancer (non-metastatic)
Q37301438Breast cancer multifocality and multicentricity and locoregional recurrence
Q37588495Breast-conserving surgery after neoadjuvant chemotherapy in patients with locally advanced cancer. Preliminary results
Q73594784Clinical outcomes of post-operative locoregional radiotherapy in pre-menopausal and post-menopausal Chinese women with breast cancer
Q34439046Comprehensive review of the management of internal mammary lymph node metastases in breast cancer
Q74682562Diagnostic thoracic-computed tomography in radiotherapy for loco-regional recurrent breast carcinoma
Q73301112Electron arc irradiation of the postmastectomy chest wall: clinical results
Q33678514Evaluation of predictive factors for local tumour control after electron-beam-rotation irradiation of the chest wall in locally advanced breast cancer
Q35182953Evidence-based indications for postmastectomy irradiation
Q73399930Immediate breast reconstruction-impact on radiation management
Q43564746Local hyperthermia, radiation, and chemotherapy in recurrent breast cancer is feasible and effective except for inflammatory disease
Q34025384Local recurrence after mastectomy and adjuvant CMF: implications for adjuvant radiation therapy
Q40807197Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation.
Q43962683Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy
Q33667577Locoregional failure rates in patients with involved axillary nodes after mastectomy and systemic therapy
Q73415856Locoregional first recurrence after mastectomy: prospective cohort studies with and without immediate chemotherapy
Q41540056Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence
Q73181186Management of axillary lymph nodes in breast cancer: a national patterns of care study of 17,151 patients
Q34477295Metaplastic breast cancer: to radiate or not to radiate?
Q44723855Molecular markers for prognosis after isolated postmastectomy chest wall recurrence
Q61773574Molecular profiles and clinical outcome of stage UICC II colon cancer patients
Q34678391Occult breast cancer and axillary mass.
Q57403362Oestrogen receptor status predicts local recurrence following breast conservation surgery for early breast cancer
Q47182699Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy
Q24186275Post-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodes
Q24203952Post-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodes
Q33667601Postmastectomy irradiation: rationale for treatment field selection
Q33667584Postmastectomy radiation in patients with one to three positive axillary nodes receiving adjuvant chemotherapy: An unresolved issue
Q38169576Postmastectomy radiation therapy
Q33667619Postmastectomy radiation therapy: A surgical perspective
Q73155399Postmastectomy radiation: a modest benefit prevails for high risk patients
Q77911483Postmastectomy radiotherapy: randomized trials
Q34401140Preoperative MRI improves prediction of extensive occult axillary lymph node metastases in breast cancer patients with a positive sentinel lymph node biopsy.
Q47207357Prognostic significance of apex axillary invasion for locoregional recurrence and effect of postmastectomy radiotherapy on overall survival in node-positive breast cancer patients.
Q73941814Pulmonary sequelae of treatment for breast cancer: a prospective study
Q43681935Radiation therapy after breast reconstruction: outcomes, complications, and patient satisfaction.
Q77525781Radiation therapy for chest wall recurrence of breast cancer after mastectomy in a favorable subgroup of patients
Q37602386Radiation therapy for early breast cancer
Q67830319Radiation therapy in breast conservation patients and postmastectomy
Q44066642Radiotherapy following mastectomy: indication and contraindication of chest wall irradiation
Q30990725Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation
Q52952801Role of axillary ultrasound, magnetic resonance imaging, and ultrasound-guided fine-needle aspiration biopsy in the preoperative triage of breast cancer patients.
Q33667592Role of postmastectomy radiotherapy: A medical oncology perspective
Q33855425Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?
Q40931740Surgical and medical management of local-regional treatment failures in advanced primary breast cancer.
Q79349495Surgical treatment for invasive lobular carcinoma of the breast
Q73978343The acute effects of postoperative radiation therapy on the transverse rectus abdominis myocutaneous flap used in immediate breast reconstruction
Q33757672The crucial role of adjuvant irradiation after surgery for breast cancer
Q73665822The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or = 10 positive axillary nodes
Q73980803The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy
Q33779190The role of radiation therapy for primary breast cancer
Q78257194Treatment of early-stage breast cancer
Q36072442Treatment options for metaplastic breast cancer
Q77734723[Influence of locoregional irradiation on local control and survival in breast cancer]
Q73609479[Postmastectomy locoregional radiotherapy for breast cancer: literature review]
Q77200784[Radiotherapy of the breast and chest wall: treatment volume]

Search more.